期刊文献+

血清25-羟基维生素D和骨钙素水平对2型糖尿病患者病程转归的预警价值 被引量:10

Warning effects of serum 25-hydroxyvitamin D and osteocalcin levels on the progression of type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨血清25-羟基维生素D(25-hydroxyvitaminD,25-OH-VD)和骨钙素(osteocalcin,OC)水平对2型糖尿病(type 2diabetes mellitus,T2DM)病程转归的预警价值。方法:选取2013年1月至12月在复旦大学附属金山医院内分泌科住院治疗的T2DM患者116例作为病例组,对照组为2013年在我院门诊体检的健康体检者50例,比较两组的年龄、体质指数(body mass index,BMI)、空腹血糖(fasting blood glucose,FBG)、血脂、血压、25-OH-VD及OC等生理指标。分析病例组25-OH-VD和OC与糖尿病肾病的相关性,进一步采用多元逐步回归分析25-OH-VD和OC水平与血脂、血压、BMI、FBG、糖化血红蛋白(glycosylated hemoglobin,HbA1c)、空腹胰岛素(fast insulin,FINS)、胰岛素抵抗指数(homeostasis model assessment for insulin resistance index,HOMA-IR)、肌酐(creatinine,CR)、尿酸(uric acid,UA)和颈动脉内膜中层厚度(carotid artery intimal medial thickness,CA-IMT)之间的相关性。结果:病例组与对照组在年龄、血压、BMI和血脂间的差异无统计学意义,但病例组25-OH-VD水平低于正常对照组[(13.91±7.13)ng/mL vs(30.35±19.7)ng/mL,P=0.000],病例组OC也低于对照组[(4.02±1.66)ng/mL vs(6.62±1.68)ng/mL,P=0.000]。病例组中,肾病患者的25-OH-VD水平明显低于尿微量白蛋白(urine microalbumin,U-MA)正常者[(10.33±3.46)ng/mL vs(16.45±7.95)ng/mL,P=0.000],而两者之间OC水平差异无统计学意义[(3.91±1.67)ng/mL vs(4.09±1.67)ng/mL,P=0.558]。T2DM患者的25-OH-VD水平与BMI、血脂、血压、FBG、HbA1c、FINS、HOMA-IR、CR、UA和CA-IMT均无明显相关性。T2DM患者的OC水平与FBG、HbA1c和HOMAIR负相关,而与FINS、CR和CA-IMF正相关,HbA1c和FBG是OC的独立影响因素。结论:血清25-OH-VD和OC可作为T2DM病情进展的预警信号,25-OH-VD与糖尿病肾脏并发症的发生发展相关,OC则与糖尿病微血管病变的进展相关。 Objective:To explore the warning effect of serum levels of 25-hydroxy vitamin D (25-OH-VD) and osteocalcin(OC) with the prognosis of type 2 diabetes mellitus (T2DM).Methods:The case group of 116 cases of T2DM were selected from the patients hospitalizedin the department of endocrinology, Jinshan Hospital, Fudan University from Jan.to Dec.in 2013, and 50 cases of health volunteers from the outpatient of physical examination in our hospital were collected as the control group.The age, body mass index(BMI), fasting blood glucose (FBG), blood lipid, blood pressure and 25-OH-VD and OC were compared between the two groups.In the case group, the correlation of 25-OH-VD and OC with nephropathy were analyzed, and then multiple stepwise regression was used to analyze the statistical relationship of 25-OH-VD and OC with blood lipid, blood pressure, BMI, FBG, glycosylated hemoglobin (HbA1c), fast insulin (FINS), homeostasis model assessment for insulin resistance index (HOMA-IR), creatinine (CR), uric acid (UA)and carotid artery intimal medial thickness (CA-IMT).Results:There was no statistical difference in age, blood pressure, BMI and blood lipid between the case group and the control group, while the levels of 25-OH-VD and OC were lower in the case group compared with the control group ([13.91±7.13] ng/mL vs [30.35±19.7] ng/mL, P=0.000;[4.02±1.66] ng/mL vs [6.62±1.68] ng/mL, P=0.000).In the case group, patients with nephropathy had lower 25-OH-VD level than those with normal urine microalbumin (U-MA) ([10.33±3.46] ng/mL vs [16.45±7.95] ng/mL,P=0.000), while there was no statistical difference in OC level ([3.91±1.67] ng/mL vs [4.09±1.67] ng/mL, P=0.558).25-OH-VD level of T2DM patients has no correlation with BMI, blood lipid, blood pressure, FBG, HbA1c, FINS, HOMA-IR, CR, UA and CA-IMT.OC level of T2DM patients has negative correlation with FBG, HbA1c and HOMA-IR, and positive correlation with FINS, CR
出处 《中国临床医学》 2017年第3期382-386,共5页 Chinese Journal of Clinical Medicine
基金 上海市金山区卫计委基金(JSKJ-KTQN-2014-06)~~
关键词 2型糖尿病 25-羟基维生素D 骨钙素 25-羟基维生素D type 2 diabetes mellitus 25-hydroxy vitamin D osteocalcin
  • 相关文献

参考文献2

二级参考文献20

  • 1Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease : results of the study to evaluate early kidney disease [ J ]. Kidney Int,2007,71:31 - 38. 被引量:1
  • 2Ravani P,Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease [ J ]. Kidney Int, 2009,75 (1) :88 -95. 被引量:1
  • 3Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients [ J ]. Kidney Int, 2007,72 : 1004 - 1013. 被引量:1
  • 4Kovesdy CP, Ahmadzadeh S, Anderson JE, et al. Association of treatment with activated vitamin D and mortality in chronic kidney disease [ J ]. Arch Intern Med,2008,25,168:397 - 403. 被引量:1
  • 5Lee GH, Benner D, Regidor DL, et al. Impact of kidney bone disease and its management on survival of patients on dialysis [ J ]. J Ren Nutr,2007 ,17 :38 -44. 被引量:1
  • 6Bises G, Kallay E, Weiland T, et al. 25-hydroxyvitamin D3-1ahydroxylase expression in normal and malignant human colon[ J]. J Histochem Cytochem,2004,52:985 - 989. 被引量:1
  • 7Forouhi NG, Luan J, Cooper A, et al. Baseline serum 25-hydroxy vitamin d is predietive of future glycemic status and insulin resistance:the Medical Researeh Couneil Ely Prospective Study 1990-- 2000 [ J ]. Diabetes,2008,57 (10) :2619 - 2625. 被引量:1
  • 8Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults [ J ]. J Nutr,2009,139 (2) :329 - 334. 被引量:1
  • 9Nashold FE, Spach KM, Spanier JA, et al. Estrogen Controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression[ J]. J Immunol,2009 ,15 ,183 (6 ) :3672 - 3681. 被引量:1
  • 10Ravani P, Malberti F, Tripepi G, eta]. Vitamin D levels and patient outcome in chronic kidney disease [ J ]. Kidney Int,2009,75 (l) : 88 - 95. 被引量:1

共引文献40

同被引文献131

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部